Applied Biochemistry and Biotechnology

, Volume 165, Issue 7–8, pp 1628–1651

Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms

  • Alicia Fernandez-Fernandez
  • Romila Manchanda
  • Anthony J. McGoron
Article

Abstract

Successful cancer management depends on accurate diagnostics along with specific treatment protocols. Current diagnostic techniques need to be improved to provide earlier detection capabilities, and traditional chemotherapy approaches to cancer treatment are limited by lack of specificity and systemic toxicity. This review highlights advances in nanotechnology that have allowed the development of multifunctional platforms for cancer detection, therapy, and monitoring. Nanomaterials can be used as MRI, optical imaging, and photoacoustic imaging contrast agents. When used as drug carriers, nanoformulations can increase tumor exposure to therapeutic agents and result in improved treatment effects by prolonging circulation times, protecting entrapped drugs from degradation, and enhancing tumor uptake through the enhanced permeability and retention effect as well as receptor-mediated endocytosis. Multiple therapeutic agents such as chemotherapy, antiangiogenic, or gene therapy agents can be simultaneously delivered by nanocarriers to tumor sites to enhance the effectiveness of therapy. Additionally, imaging and therapy agents can be co-delivered to provide seamless integration of diagnostics, therapy, and follow-up, and different therapeutic modalities such as chemotherapy and hyperthermia can be co-administered to take advantage of synergistic effects. Liposomes, metallic nanoparticles, polymeric nanoparticles, dendrimers, carbon nanotubes, and quantum dots are examples of nanoformulations that can be used as multifunctional platforms for cancer theranostics. Nanomedicine approaches in cancer have great potential for clinically translatable advances that can positively impact the overall diagnostic and therapeutic process and result in enhanced quality of life for cancer patients. However, a concerted scientific effort is still necessary to fully explore long-term risks, effects, and precautions for safe human use.

Keywords

Nanocarriers Multifunctional nanoparticles Theranostics Cancer Nanomaterials Image-guided therapy 

References

  1. 1.
    Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010). A Cancer Journal for Clinicians, 60, 267–300.Google Scholar
  2. 2.
    Wang, X., Wang, Y., Chen, Z. G., & Shin, D. M. (2009). Cancer Research Treatment, 41, 1–11.CrossRefGoogle Scholar
  3. 3.
    Ehlrich, P. (1906). Collected studies on immunity (pp. 404–443). New York: Wiley.Google Scholar
  4. 4.
    Kreuter, J. (1996). Journal of Anatomy, 189(Pt 3), 503–505.Google Scholar
  5. 5.
    Breimer, D. D. (1998). Advanced Drug Delivery Reviews, 33, 265–268.CrossRefGoogle Scholar
  6. 6.
    Brandl, M. (2001). Biotechnology Annual Review, 7, 59–85.CrossRefGoogle Scholar
  7. 7.
    de Estella-Hermoso, M. A., Campanero, M. A., Mollinedo, F., & Blanco-Prieto, M. J. (2009). Journal of Biomedical Nanotechnology, 5, 323–343.CrossRefGoogle Scholar
  8. 8.
    Matsumura, Y., Hamaguchi, T., Ura, T., et al. (2004). British Journal of Cancer, 91, 1775–1781.CrossRefGoogle Scholar
  9. 9.
    Lee, J. H., Jung, S. W., Kim, I. S., et al. (2003). International Journal of Pharmaceutics, 251, 23–32.CrossRefGoogle Scholar
  10. 10.
    Liu, Z. H., Jiao, Y. P., Wang, Y. F., et al. (2008). Advanced Drug Delivery Reviews, 60, 1650–1662.CrossRefGoogle Scholar
  11. 11.
    Xu, Z. P., Zeng, Q. H., Lu, G. Q., & Yu, A. B. (2006). Chemical Engineering Science, 61, 1027–1040.CrossRefGoogle Scholar
  12. 12.
    Dakhil, S., Ensminger, W., Cho, K., et al. (1982). Cancer, 50, 631–635.CrossRefGoogle Scholar
  13. 13.
    Nelken, N., & Schneider, P. A. (2004). Surgical Clinics of North America, 84, 1203–1236.CrossRefGoogle Scholar
  14. 14.
    Gregoriadis, G., Leathwood, P. D., & Ryman, B. E. (1971). FEBS Letters, 14, 95–99.CrossRefGoogle Scholar
  15. 15.
    Gregoriadis, G., & Ryman, B. E. (1972). European Journal of Biochemistry, 24, 485–491.CrossRefGoogle Scholar
  16. 16.
    Banerjee, R. (2001). Journal of Biomaterials Applications, 16, 3–21.CrossRefGoogle Scholar
  17. 17.
    Axelsson, B. (1989). Advanced Drug Delivery Reviews, 3, 391–404.CrossRefGoogle Scholar
  18. 18.
    Bakker-Woudenberg, I., Lokerse, A., ten Kate, M., et al. (1993). European Journal of Clinical Microbiology, 12, S61–S67.CrossRefGoogle Scholar
  19. 19.
    Lestini, B. J., Sagnella, S. M., Xu, Z., et al. (2002). Journal of Controlled Release, 78, 235–247.CrossRefGoogle Scholar
  20. 20.
    Tarahovsky, Y. S. (2010). Biochemistry (Mosc), 75, 811–824.CrossRefGoogle Scholar
  21. 21.
    Strother, R., & Matei, D. (2009). Therapeutic Clinical Risk Management, 5, 639–650.Google Scholar
  22. 22.
    Fassas, A., & Anagnostopoulos, A. (2005). Leukemia & Lymphoma, 46, 795–802.CrossRefGoogle Scholar
  23. 23.
    Sapra, P., Tyagi, P., & Allen, T. M. (2005). Current Drug Delivery, 2, 369–381.CrossRefGoogle Scholar
  24. 24.
    Sarris, A. H., Hagemeister, F., Romaguera, J., et al. (2000). Annals of Oncology, 11, 69–72.CrossRefGoogle Scholar
  25. 25.
    Chhikara, B. S., & Parang, K. (2010). Expert Opinion on Drug Delivery, 7, 1399–1414.CrossRefGoogle Scholar
  26. 26.
    Cattel, L., Ceruti, M., & Dosio, F. (2003). Tumori, 89, 237–249.Google Scholar
  27. 27.
    Salzberg, M., Thurlimann, B., Bonnefois, H., et al. (2005). Oncology, 68, 293–298.CrossRefGoogle Scholar
  28. 28.
    Cheung, T. W., Remick, S. C., Azarnia, N., et al. (1999). Clinical Cancer Research, 5, 3432–3437.Google Scholar
  29. 29.
    Koukourakis, M. I., Koukouraki, S., Giatromanolaki, A., et al. (1999). Journal of Clinical Oncology, 17, 3512–3521.Google Scholar
  30. 30.
    Caponigro, F., Comella, P., Budillon, A., et al. (2000). Annals of Oncology, 11, 339–342.CrossRefGoogle Scholar
  31. 31.
    Roerdink, F., Dijkstra, J., Hartman, G., et al. (1981). BBA General Subjects, 677, 79–89.CrossRefGoogle Scholar
  32. 32.
    Blume, G., Cevc, G., Crommelin, M. D. J. A., et al. (1993). BBA Review Biomembranes, 1149, 180–184.CrossRefGoogle Scholar
  33. 33.
    Mori, A., Klibanov, A. L., Torchilin, V. P., & Huang, L. (1991). FEBS Letters, 284, 263–266.CrossRefGoogle Scholar
  34. 34.
    Allen, T. M. (1994). Advanced Drug Delivery Reviews, 13, 285–309.CrossRefGoogle Scholar
  35. 35.
    Burger, J. J., Tomlinson, E., Mulder, E. M. A., & McVie, J. G. (1985). International Journal of Pharmaceutics, 23, 333–344.CrossRefGoogle Scholar
  36. 36.
    Anderson, J. M., & Shive, M. S. (1997). Advanced Drug Delivery Reviews, 28, 5–24.CrossRefGoogle Scholar
  37. 37.
    Birrenbach, G. S. P. (1976). Journal of Pharmaceutical Sciences, 65, 1763.CrossRefGoogle Scholar
  38. 38.
    Avgoustakis, K. (2004). Current Drug Delivery, 1, 321–333.CrossRefGoogle Scholar
  39. 39.
    Fahmy, T. M., Fong, P. M., Goyal, A., & Saltzman, W. M. (2005). Materials Today, 8, 18–26.CrossRefGoogle Scholar
  40. 40.
    Chung, Y. I., Kim, J. C., Kim, Y. H., et al. (2010). Journal of Controlled Release, 143, 374–382.CrossRefGoogle Scholar
  41. 41.
    Nicolas, J., & Couvreur, P. (2009). Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 1, 111–127.CrossRefGoogle Scholar
  42. 42.
    Kumari, A., Yadav, S. K., & Yadav, S. C. (2009). Colloid Surface B, 75, 1–18.CrossRefGoogle Scholar
  43. 43.
    Nagpal, K., Singh, S. K., & Mishra, D. N. (2010). Chemical and Pharmaceutical Bulletin (Tokyo), 58, 1423–1430.CrossRefGoogle Scholar
  44. 44.
    Jayakumar, R., Prabaharan, M., Nair, S. V., & Tamura, H. (2010). Biotechnology Advances, 28, 142–150.CrossRefGoogle Scholar
  45. 45.
    Dash, M., Chiellini, F., Ottenbrite, R., & Chiellini, E. (2011). Progress in Polymer Science, 36, 981–1014.CrossRefGoogle Scholar
  46. 46.
    Corsi, K., Chellat, F., Yahia, L., & Fernandes, J. C. (2003). Biomaterials, 24, 1255–1264.CrossRefGoogle Scholar
  47. 47.
    Erbacher, P., Zou, S., Bettinger, T., et al. (1998). Pharmaceutical Research, 15, 1332–1339.CrossRefGoogle Scholar
  48. 48.
    Kumar, M., Behera, A. K., Lockey, R. F., et al. (2002). Human Gene Therapy, 13, 1415–1425.CrossRefGoogle Scholar
  49. 49.
    Kievit, F. M., Veiseh, O., Bhattarai, N., et al. (2009). Advanced Functional Materials, 19, 2244–2251.CrossRefGoogle Scholar
  50. 50.
    Tripathi, S. K., Goyal, R., Kumar, P., & Gupta, K. C. (2011). Nanomedicine. doi:10.1016/j.nano.2011.06.022.
  51. 51.
    Aktas, Y., Andrieux, K., Alonso, M. J., et al. (2005). International Journal of Pharmaceutics, 298, 378–383.CrossRefGoogle Scholar
  52. 52.
    Karatas, H., Aktas, Y., Gursoy-Ozdemir, Y., et al. (2009). Journal of Neuroscience, 29, 13761–13769.CrossRefGoogle Scholar
  53. 53.
    Son, Y. J., Jang, J. S., Cho, Y. W., et al. (2003). Journal of Controlled Release, 91, 135–145.CrossRefGoogle Scholar
  54. 54.
    Mitra, S., Gaur, U., Ghosh, P. C., & Maitra, A. N. (2001). Journal of Controlled Release, 74, 317–323.CrossRefGoogle Scholar
  55. 55.
    Janes, K. A., Fresneau, M. P., Marazuela, A., et al. (2001). Journal of Controlled Release, 73, 255–267.CrossRefGoogle Scholar
  56. 56.
    Lee, E., Lee, J., Lee, I. H., et al. (2008). Journal of Medicinal Chemistry, 51, 6442–6449.CrossRefGoogle Scholar
  57. 57.
    Min, K. H., Park, K., Kim, Y. S., et al. (2008). Journal of Controlled Release, 127, 208–218.CrossRefGoogle Scholar
  58. 58.
    Hwang, H. Y., Kim, I. S., Kwon, I. C., & Kim, Y. H. (2008). Journal of Controlled Release, 128, 23–31.CrossRefGoogle Scholar
  59. 59.
    Ohya, Y., Takei, T., Kobayashi, H., & Ouchi, T. (1993). Journal of Microencapsulation, 10, 1–9.CrossRefGoogle Scholar
  60. 60.
    Wang, X., Li, Y., & Du, Y. (2009). Journal of Nanoscience and Nanotechnology, 9, 6866–6875.Google Scholar
  61. 61.
    Cheong, S. J., Lee, C. M., Kim, S. L., et al. (2009). International Journal of Pharmaceutics, 372, 169–176.CrossRefGoogle Scholar
  62. 62.
    Nam, T., Park, S., Lee, S. Y., et al. (2010). Bioconjugate Chemistry, 21, 578–582.CrossRefGoogle Scholar
  63. 63.
    Baldrick, P. (2010). Regulatory Toxicology and Pharmacology, 56, 290–299.CrossRefGoogle Scholar
  64. 64.
    Acharya, S., & Sahoo, S. K. (2011). Advanced Drug Delivery Reviews, 63, 170–183.Google Scholar
  65. 65.
    Yoo, H. S., Lee, K. H., Oh, J. E., & Park, T. G. (2000). Journal of Controlled Release, 68, 419–431.CrossRefGoogle Scholar
  66. 66.
    Park, J., Fong, P. M., Lu, J., et al. (2009). Nanomedicine, 5, 410–418.CrossRefGoogle Scholar
  67. 67.
    Bhardwaj, V., Ankola, D. D., Gupta, S. C., et al. (2009). Pharmaceutical Research, 26, 2495–2503.CrossRefGoogle Scholar
  68. 68.
    Gradishar, W. J., Tjuladin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., et al. (2005). J Clin Oncol, 23, 7794–7803.CrossRefGoogle Scholar
  69. 69.
    Reynolds, C., Barrera, D., Jotte, R., et al. (2009). Journal of Thoracic Oncology, 4, 1537–1543.CrossRefGoogle Scholar
  70. 70.
    Nyman, D. W., Campbell, K. J., Hersh, E., et al. (2005). Journal of Clinical Oncology, 23, 7785–7793.CrossRefGoogle Scholar
  71. 71.
    Tang, Y., Lei, T., Manchanda, R., et al. (2010). Pharmaceutical Research, 27, 2242–2253.CrossRefGoogle Scholar
  72. 72.
    Song, X. R., Cai, Z., Zheng, Y., et al. (2009). European Journal of Pharmaceutical Sciences, 37, 300–305.CrossRefGoogle Scholar
  73. 73.
    Agueros, M., Areses, P., Campanero, M. A., et al. (2009). European Journal of Pharmaceutical Sciences, 37, 231–240.CrossRefGoogle Scholar
  74. 74.
    Balthasar, S., Michaelis, K., Dinauer, N., et al. (2005). Biomaterials, 26, 2723–2732.CrossRefGoogle Scholar
  75. 75.
    Cheng, F. Y., Su, C. H., Wu, P. C., & Yeh, C. S. (2010). Chemical Communications (Cambridge, England), 46, 3167–3169.CrossRefGoogle Scholar
  76. 76.
    Cho, H. S., Dong, Z., Pauletti, G. M., et al. (2010). ACS Nano, 4, 5398–5404.CrossRefGoogle Scholar
  77. 77.
    Dai, H., Jiang, X., Tan, G. C., et al. (2006). International Journal of Nanomedecine, 1, 507–522.CrossRefGoogle Scholar
  78. 78.
    Danhier, F., Vroman, B., Lecouturier, N., et al. (2009). Journal of Controlled Release, 140, 166–173.CrossRefGoogle Scholar
  79. 79.
    Derakhshandeh, K., Soheili, M., Dadashzadeh, S., & Saghiri, R. (2010). International Journal of Nanomedecine, 5, 463–471.CrossRefGoogle Scholar
  80. 80.
    ElBayoumi, T. A., & Torchilin, V. P. (2009). Clinical Cancer Research, 15, 1973–1980.CrossRefGoogle Scholar
  81. 81.
    Huh, M. S., Lee, S. Y., Park, S., et al. (2010). Journal of Controlled Release, 144, 134–143.CrossRefGoogle Scholar
  82. 82.
    Jain, A. K., Swarnakar, N. K., Godugu, C., et al. (2011). Biomaterials, 32, 503–515.CrossRefGoogle Scholar
  83. 83.
    Jiang, X., Dai, H., Leong, K. W., et al. (2006). The Journal of Gene Medicine, 8, 477–487.CrossRefGoogle Scholar
  84. 84.
    Kim, K., Kim, J. H., Park, H., et al. (2010). Journal of Controlled Release, 146, 219–227.CrossRefGoogle Scholar
  85. 85.
    Kocbek, P., Obermajer, N., Cegnar, M., et al. (2007). Journal of Controlled Release, 120, 18–26.CrossRefGoogle Scholar
  86. 86.
    Lee, S. M., Park, H., & Yoo, K. H. (2010). Advanced Materials, 22, 4049–4053.CrossRefGoogle Scholar
  87. 87.
    Liu, Y., Li, K., Liu, B., & Feng, S. S. (2010). Biomaterials, 31, 9145–9155.CrossRefGoogle Scholar
  88. 88.
    Misra, R., & Sahoo, S. K. (2010). European Journal of Pharmaceutical Sciences, 39, 152–163.CrossRefGoogle Scholar
  89. 89.
    Musumeci, T., Ventura, C. A., Giannone, I., et al. (2006). International Journal of Pharmaceutics, 325, 172–179.CrossRefGoogle Scholar
  90. 90.
    Pille, J. Y., Li, H., Blot, E., et al. (2006). Human Gene Therapy, 17, 1019–1026.CrossRefGoogle Scholar
  91. 91.
    Qu, J., Liu, G., Wang, Y., & Hong, R. (2010). Advanced Powder Technology, 21, 461–467.CrossRefGoogle Scholar
  92. 92.
    Sahana, B., Santra, K., Basu, S., & Mukherjee, B. (2010). International Journal of Nanomedicine, 5, 621–630.Google Scholar
  93. 93.
    Saxena, V., Sadoqi, M., & Shao, J. (2006). International Journal of Pharmaceutics, 308, 200–204.CrossRefGoogle Scholar
  94. 94.
    Wang, H., Zhao, P., Su, W., et al. (2010). Biomaterials, 31, 8741–8748.CrossRefGoogle Scholar
  95. 95.
    Wang, J., Tao, X., Zhang, Y., et al. (2010). Biomaterials, 31, 4426–4433.CrossRefGoogle Scholar
  96. 96.
    Wu, P., He, X., Wang, K., et al. (2009). Journal of Biomedical Nanotechnology, 5, 557–564.CrossRefGoogle Scholar
  97. 97.
    Yallapu, M. M., Gupta, B. K., Jaggi, M., & Chauhan, S. C. (2010). Journal of Colloid and Interface Science, 351, 19–29.CrossRefGoogle Scholar
  98. 98.
    Maeda, H., Wu, J., Sawa, T., et al. (2000). Journal of Controlled Release, 65, 271–284.CrossRefGoogle Scholar
  99. 99.
    Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009). European Journal of Pharmaceutics and Biopharmaceutics, 71, 409–419.CrossRefGoogle Scholar
  100. 100.
    Hall, J. B., Dobrovolskaia, M. A., Patri, A. K., & McNeil, S. E. (2007). Nanomedicine, 2, 789–803.CrossRefGoogle Scholar
  101. 101.
    Seymour, L. W., Miyamoto, Y., Maeda, H., et al. (1995). European Journal of Cancer, 31, 766–770.CrossRefGoogle Scholar
  102. 102.
    Tolcher, A. W., Sugarman, S., Gelmon, K. A., et al. (1999). Journal of Clinical Oncology, 17, 478–484.Google Scholar
  103. 103.
    Brennan, F. R., Shaw, L., Wing, M. G., & Robinson, C. (2004). Molecular Biotechnology, 27, 59–74.CrossRefGoogle Scholar
  104. 104.
    Chang, H. R. (2010). Cancer, 116, 2856–2867.CrossRefGoogle Scholar
  105. 105.
    Glass, B., Ziepert, M., Reiser, M., et al. (2010). Annals of Oncology, 21, 2255–2261.CrossRefGoogle Scholar
  106. 106.
    Yoon, D. H., Choi, D. R., Ahn, H. J., et al. (2010). European Journal of Haematology, 85, 149–157.Google Scholar
  107. 107.
    Frampton, J. E., & Keating, G. M. (2008). BioDrugs, 22, 113–120.CrossRefGoogle Scholar
  108. 108.
    Kanwar, J. R., Mahidhara, G., & Kanwar, R. K. (2011). Drug Discovery Today, 16, 188–202.CrossRefGoogle Scholar
  109. 109.
    Lee, J. F., Hesselberth, J. R., Meyers, L. A., & Ellington, A. D. (2004). Nucleic Acids Research, 32(D95), 100.CrossRefGoogle Scholar
  110. 110.
    Ruckman, J., Green, L., Beeson, J., et al. (1998). Journal of Biological Chemistry, 273, 20556–20567.CrossRefGoogle Scholar
  111. 111.
    Kourlas, H., & Schiller, D. S. (2006). Clinical Therapeutics, 28, 36–44.CrossRefGoogle Scholar
  112. 112.
    Farokhzad, O. C., Cheng, J. J., Teply, B. A., et al. (2006). Proceedings of the National Academy of Sciences of the United States of America, 103, 6315–6320.CrossRefGoogle Scholar
  113. 113.
    Toffoli, G., Cernigoi, C., Russo, A., et al. (1997). International Journal of Cancer, 74, 193–198.CrossRefGoogle Scholar
  114. 114.
    Parker, N., Turk, M. J., Westrick, E., et al. (2005). Analytical Biochemistry, 338, 284–293.CrossRefGoogle Scholar
  115. 115.
    Park, J. W., Hong, K. L., Kirpotin, D. B., et al. (2002). Clinical Cancer Research, 8, 1172–1181.Google Scholar
  116. 116.
    Lei, T., Srinivasan, S., Tang, Y., et al. (2011). Nanomedicine and Nanotechnology, 7, 324–332.CrossRefGoogle Scholar
  117. 117.
    Agrawal, V., Paul, M. K., & Mukhopadhyay, A. K. (2005). Journal of Liposome Research, 15, 141–155.CrossRefGoogle Scholar
  118. 118.
    Song, X. R., Zheng, Y., He, G., et al. (2010). Journal of Pharmaceutical Sciences, 99, 4874–4879.CrossRefGoogle Scholar
  119. 119.
    Soma, C. E., Dubernet, C., Bentolila, D., et al. (2000). Biomaterials, 21, 1–7.CrossRefGoogle Scholar
  120. 120.
    Fan, L., Li, F., Zhang, H. T., et al. (2010). Biomaterials, 31, 5634–5642.CrossRefGoogle Scholar
  121. 121.
    Tardi, P., Johnstone, S., Harasyrn, N., et al. (2009). Leukemia Research, 33, 129–139.CrossRefGoogle Scholar
  122. 122.
    Harasym, T. O., Tardi, P. G., Harasym, N. L., et al. (2007). Oncology Research, 16, 361–374.Google Scholar
  123. 123.
    Guo, J., Zhou, J., Ying, X., et al. (2010). Journal of Pharmacy and Pharmacology Science, 13, 136–151.Google Scholar
  124. 124.
    Jiang, J. A., Yang, S. J., Wang, J. C., et al. (2010). European Journal of Pharmaceutics and Biopharmaceutics, 76, 170–178.CrossRefGoogle Scholar
  125. 125.
    Zhang, L., Radovic-Moreno, A. F., Alexis, F., et al. (2007). ChemMedChem, 2, 1268–1271.CrossRefGoogle Scholar
  126. 126.
    Fayette, M., Soria, J. C., & Armand, J. P. (2005). European Journal of Cancer, 41, 1109–1116.CrossRefGoogle Scholar
  127. 127.
    Emanuel, S., Gruninger, R. H., Fuentes-Pesquera, A., et al. (2004). Molecular Pharmaceutics, 66, 635–647.Google Scholar
  128. 128.
    Ma, J., & Waxman, D. J. (2008). Molecular Cancer Therapeutics, 7, 3670–3684.CrossRefGoogle Scholar
  129. 129.
    Couzin, J. (2002). Science, 296, 2314–2315.CrossRefGoogle Scholar
  130. 130.
    Sengupta, S., Eavarone, D., Capila, I., et al. (2005). Nature, 436, 568–572.CrossRefGoogle Scholar
  131. 131.
    Liu, F., Shollenberger, L. M., & Huang, L. (2004). The FASEB Journal, 18, 1779–1781.CrossRefGoogle Scholar
  132. 132.
    Wang, Y., Gao, S. J., Ye, W. H., et al. (2006). Nature Materials, 5, 791–796.CrossRefGoogle Scholar
  133. 133.
    Devi, G. R. (2006). Cancer Gene Therapy, 13, 819–829.CrossRefGoogle Scholar
  134. 134.
    Zhu, C., Jung, S., Luo, S., et al. (2010). Biomaterials, 31, 2408–2416.CrossRefGoogle Scholar
  135. 135.
    Chen, Y. C., Bathula, S. R., Li, J., & Huang, L. (2010). Journal of Biological Chemistry, 285, 22639–22650.CrossRefGoogle Scholar
  136. 136.
    Chen, Y. C., Wu, J. Z. J., & Huang, L. (2010). Molecular Therapy, 18, 828–834.CrossRefGoogle Scholar
  137. 137.
    Saad, M., Garbuzenko, O. B., & Minko, T. (2008). Nanomedicine, 3, 761–776.CrossRefGoogle Scholar
  138. 138.
    Sun, T. M., Du, J. Z., Yao, Y. D., et al. (2011). Acs Nano , 5(2), 1483–1494.Google Scholar
  139. 139.
    Minelli, C., Lowe, S. B., & Stevens, M. M. (2010). Small, 6, 2336–2357.CrossRefGoogle Scholar
  140. 140.
    Grubisha, D. S., Lipert, R. J., Park, H. Y., et al. (2003). Analytical Chemistry, 75, 5936–5943.CrossRefGoogle Scholar
  141. 141.
    Gerion, D., Chen, F., Kannan, B., et al. (2003). Analytical Chemistry, 75, 4766–4772.CrossRefGoogle Scholar
  142. 142.
    Xia, Z., Xing, Y., So, M. K., et al. (2008). Analytical Chemistry, 80, 8649–8655.CrossRefGoogle Scholar
  143. 143.
    Asami, Y., Oishi, J., Kitazaki, H., et al. (2011). Anal Biochem, 418, 44–49.Google Scholar
  144. 144.
    Hill, H. D., & Mirkin, C. A. (2006). Nature Protocols, 1, 324–336.CrossRefGoogle Scholar
  145. 145.
    Stoeva, S. I., Lee, J. S., Smith, J. E., et al. (2006). Journal of the American Chemical Society, 128, 8378–8379.CrossRefGoogle Scholar
  146. 146.
    Simpson, C. R., Kohl, M., Essenpreis, M., & Cope, M. (1998). Physics in Medicine and Biology, 43, 2465–2478.CrossRefGoogle Scholar
  147. 147.
    Weissleder, R., Tung, C. H., Mahmood, U., & Bogdanov, A. (1999). Nature Biotechnology, 17, 375–378.CrossRefGoogle Scholar
  148. 148.
    Lee, H. Y., Li, Z., Chen, K., et al. (2008). Journal of Nuclear Medicine, 49, 1371–1379.CrossRefGoogle Scholar
  149. 149.
    Kang, K. W. (2010). Open Nuclear Medicine Journal, 2, 153–156.Google Scholar
  150. 150.
    Yang, J., Lee, C. H., Ko, H. J., et al. (2007). Angewandte Chemie (International Ed. in English), 46, 8836–8839.CrossRefGoogle Scholar
  151. 151.
    Park, K., Lee, S., Kang, E., et al. (2009). Advances Functional Materials, 19, 1553–1566.CrossRefGoogle Scholar
  152. 152.
    Huang, X., Jain, P. K., El-Sayed, I. H., & El-Sayed, M. A. (2008). Lasers in Medical Science, 23, 217–228.CrossRefGoogle Scholar
  153. 153.
    Huff, T. B., Hansen, M. N., Zhao, Y., et al. (2007). Langmuir, 23, 1596–1599.CrossRefGoogle Scholar
  154. 154.
    Oyelere, A. K., Chen, P. C., Huang, X. H., et al. (2007). Bioconjugate Chemistry, 18, 1490–1497.CrossRefGoogle Scholar
  155. 155.
    von Maltzahn, G., Centrone, A., Park, J. H., et al. (2009). Advanced Materials, 21, 3175–3180.CrossRefGoogle Scholar
  156. 156.
    Li, C. Z., Male, K. B., Hrapovic, S., & Luong, J. H. (2005). Chemical Communications (Cambridge), 3924–3926.Google Scholar
  157. 157.
    Ann-Ann D., Ying-Yi C., Wang C.C., et al. (2008). HER-2 antibody conjugated gold nano rod for in vivo photothermal therapy. In 8th IEEE conference on Nanotechnology NANO’08, 882–885.Google Scholar
  158. 158.
    Park, H., Yang, J., Lee, J., et al. (2009). ACS Nano, 3, 2919–2926.CrossRefGoogle Scholar
  159. 159.
    Wust, P., Gneveckow, U., Johannsen, M., et al. (2006). International Journal of Hyperthermia, 22, 673–685.CrossRefGoogle Scholar
  160. 160.
    Day, E. S., Morton, J. G., & West, J. L. (2009). Journal of Biomechanical Engineering, 131, 074001.CrossRefGoogle Scholar
  161. 161.
    Dorshow, R. B., Bugaj, J. E., & Burleigh, B. D. (1998). Journal of Biomedical Optics, 3, 340–345.CrossRefGoogle Scholar
  162. 162.
    Johansen, P. L. (1990). European Heart Journal, 11(Suppl I), 6–12.Google Scholar
  163. 163.
    O’Neal, D. P., Hirsch, L. R., Halas, N. J., et al. (2004). Cancer Letters, 209, 171–176.CrossRefGoogle Scholar
  164. 164.
    Hirsch, L. R., Stafford, R. J., Bankson, J. A., et al. (2003). Proceedings of the National Academy of Sciences of the United States of America, 100, 13549–13554.CrossRefGoogle Scholar
  165. 165.
    Fernandez-Fernandez, A., Manchanda, R., Lei, T., et al. (2011). Comparative study of the optical and heat generation properties of IR820 and indocyanine green. Molecular Imaging, [Epub ahead of print].Google Scholar
  166. 166.
    Manchanda, R., Fernandez-Fernandez, A., Nagesetti, A., & McGoron, A. J. (2010). Colloid Surface B, 75, 260–267.CrossRefGoogle Scholar
  167. 167.
    Wang, Y., Li, X., Zhou, Y., et al. (2010). International Journal of Pharmaceutics, 384, 148–153.CrossRefGoogle Scholar
  168. 168.
    Gao, Z., Kennedy, A. M., Christensen, D. A., & Rapoport, N. Y. (2008). Ultrasonics, 48, 260–270.CrossRefGoogle Scholar
  169. 169.
    Rapoport, N., Nam, K. H., Gupta, R., et al. (2011). Journal of Controlled Release, 153, 4–15.CrossRefGoogle Scholar
  170. 170.
    Rapoport, N., Kennedy, A. M., Shea, J. E., et al. (2010). Molecular Pharmaceutics, 7, 22–31.CrossRefGoogle Scholar
  171. 171.
    Watanabe, Y., Horie, S., Funaki, Y., et al. (2010). Journal of Nuclear Medicine, 51, 951–958.CrossRefGoogle Scholar
  172. 172.
    Xu, J. S., Huang, J., Qin, R., et al. (2010). Biomaterials, 31, 1716–1722.CrossRefGoogle Scholar
  173. 173.
    Paparel, P., Curiel, L., Chesnais, S., et al. (2005). BJU International, 95, 881–885.CrossRefGoogle Scholar
  174. 174.
    Prat, F., Chapelon, J. Y., el Fadil, F. A., et al. (1993). British Journal of Cancer, 68, 13–17.CrossRefGoogle Scholar
  175. 175.
    Sinha, N., & Yeow, J. T. (2005). IEEE Transactions on Nanobioscience, 4, 180–195.CrossRefGoogle Scholar
  176. 176.
    De La Zerda, A., Zavaleta, C., Keren, S., et al. (2008). Nature Nanotechnology, 3, 557–562.CrossRefGoogle Scholar
  177. 177.
    Panchapakesan, B., Cesarone, G., Teker, K., & Wickstrom, E. (2006). NanoBiotechnology, 1, 353–360.CrossRefGoogle Scholar
  178. 178.
    Liu, Z., Chen, K., Davis, C., et al. (2008). Cancer Research, 68, 6652–6660.CrossRefGoogle Scholar
  179. 179.
    Panchapakesan, B., Lu, S., Sivakumar, K., et al. (2005). NanoBiotechnology, 1, 133–140.CrossRefGoogle Scholar
  180. 180.
    Poland, C. A., Duffin, R., Kinloch, I., et al. (2008). Nature Nanotechnology, 3, 423–428.CrossRefGoogle Scholar
  181. 181.
    Shvedova, A. A., Kisin, E. R., Porter, D., et al. (2009). Pharmacology and Therapeutics, 121, 192–204.CrossRefGoogle Scholar
  182. 182.
    Park, E. J., Roh, J., Kim, S. N., et al. (2011). Archives of Toxicology, 85, 1121–1131.CrossRefGoogle Scholar
  183. 183.
    Tomalia, D. A., Baker, H., Dewald, J., et al. (1986). Macromolecules, 19, 2466–2468.CrossRefGoogle Scholar
  184. 184.
    Menjoge, A. R., Kannan, R. M., & Tomalia, D. A. (2010). Drug Discovery Today, 15, 171–185.CrossRefGoogle Scholar
  185. 185.
    Zhu, S. J., Hong, M. H., Tang, G. T., et al. (2009). Biomaterials, 31, 1360–1371.CrossRefGoogle Scholar
  186. 186.
    Gerretsen, S. C., Versluis, B., Bekkers, S. C. A. M., & Leiner, T. (2008). European Journal of Radiology, 65, 80–85.CrossRefGoogle Scholar
  187. 187.
    Tekade, R. K., Dutta, T., Gajbhiye, V., & Jain, N. K. (2009). Journal of Microencapsulation, 26, 287–296.CrossRefGoogle Scholar
  188. 188.
    Lee, C. C., Gillies, E. R., Fox, M. E., et al. (2006). Proceedings of the National Academy of Sciences of the United States of America, 103, 16649–16654.CrossRefGoogle Scholar
  189. 189.
    Kobayashi, H., & Brechbiel, M. W. (2003). Molecular Imaging, 2, 1–10.CrossRefGoogle Scholar
  190. 190.
    Quintana, A., Raczka, E., Piehler, L., et al. (2002). Pharmaceutical Research, 19, 1310–1316.CrossRefGoogle Scholar
  191. 191.
    Kaneshiro, T. L., & Lu, Z. R. (2009). Biomaterials, 30, 5660–5666.CrossRefGoogle Scholar
  192. 192.
    Thomas, T. P., Shukla, R., Kotlyar, A., et al. (2010). Bioorganic & Medicinal Chemistry Letters, 20, 700–703.CrossRefGoogle Scholar
  193. 193.
    Rupp, R., Rosenthal, S. L., & Stanberry, L. R. (2007). International Journal of Nanomedicine, 2, 561–566.Google Scholar
  194. 194.
    Voura, E. B., Jaiswal, J. K., Mattoussi, H., & Simon, S. M. (2004). Nature Medicine, 10, 993–998.CrossRefGoogle Scholar
  195. 195.
    Chan, W. C., & Nie, S. (1998). Science, 281, 2016–2018.CrossRefGoogle Scholar
  196. 196.
    Guo, W., Li, J. J., Wang, Y. A., & Peng, X. (2003). Journal of the American Chemical Society, 125, 3901–3909.CrossRefGoogle Scholar
  197. 197.
    Pinaud, F., King, D., Moore, H. P., & Weiss, S. (2004). Journal of the American Chemical Society, 126, 6115–6123.CrossRefGoogle Scholar
  198. 198.
    Park, J. H., von Maltzahn, G., Ruoslahti, E., et al. (2008). Angewandte Chemie (International Ed. in English), 47, 7284–7288.CrossRefGoogle Scholar
  199. 199.
    Gao, X., Cui, Y., Levenson, R. M., et al. (2004). Nature Biotechnology, 22, 969–976.CrossRefGoogle Scholar
  200. 200.
    Derfus, A. M., Chan, W. C. W., & Bhatia, S. N. (2004). Nano Letters, 4, 11–18.CrossRefGoogle Scholar
  201. 201.
    Hondroulis, E., Liu, C., & Li, C. Z. (2010). Nanotechnology, 21, 315103.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Alicia Fernandez-Fernandez
    • 1
  • Romila Manchanda
    • 1
  • Anthony J. McGoron
    • 1
  1. 1.Department of Biomedical EngineeringFlorida International UniversityMiamiUSA

Personalised recommendations